Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Prism adaptation treatment enhances functional, cognitive outcomes in people with spatial neglect

A team of experts in post-stroke neurorehabilitation confirmed that including prism adaptation treatment in standard of care for patients with post-stroke spatial neglect improved functional and cognitive outcomes according to the Functional Independence Measure®.

26 May 2021

Researchers identify mechanism that may lead to new therapies for strokes, brain injuries

In a surprising discovery, researchers at Massachusetts General Hospital (MGH) identified a mechanism that protects the brain from the effects of hypoxia, a potentially lethal deprivation of oxygen.

26 May 2021

Kennedy Krieger Institute researcher wins NIH award for movement learning study

The National Institutes of Health (NIH) recently awarded Amy Bastian, Ph.D., PT, chief science officer and director of the Motion Analysis Lab at Kennedy Krieger Institute, with an eight-year, $4.7 million National Institute of Neurological Disorders and Stroke (NINDS) Research Program Award (N35) to support a study examining movement learning mechanisms and how this process is affected by brain damage.

26 May 2021

Researchers identify interventions to improve rehabilitation outcomes for people with spatial neglect

A recent qualitative study of rehabilitation professionals caring for people with spatial neglect enabled researchers to identify interventions to improve rehabilitation outcomes.

25 May 2021

New insights into white matter changes may offer novel targets for prevention, therapies

ince 2008, researchers at Boston University School of Medicine (BUSM) and VA Boston Healthcare System have studied Chronic Traumatic Encephalopathy (CTE), a progressive brain disease associated with repetitive head impacts that has been diagnosed after death in the brains of American football players and other contact sport athletes as well as members of the armed services.

25 May 2021

Little evidence for mRNA COVID-19 vaccine-associated thrombocytopenia, suggests new FDA study

Even as a host of vaccines have been rolled out to counter the coronavirus disease 2019 (COVID-19) pandemic, some serious adverse effects have been reported, in the form of thrombocytopenia. A new study in the journal Vaccine reports the results of an evaluation of reported cases of this condition, using data from the Vaccine Adverse Event Reporting System (VAERS).

24 May 2021

Landmark study confirms that controlled blood pressure is key to prevent stroke, heart disease

Follow-up data from the landmark SPRINT study of the effect of high blood pressure on cardiovascular disease have confirmed that aggressive blood pressure management -- lowering systolic blood pressure to less than 120 mm Hg -- dramatically reduces the risk of heart disease, stroke, and death from these diseases, as well as death from all causes, compared to lowering systolic blood pressure to less than 140 mm Hg.

22 May 2021

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.

21 May 2021

Women with history of weight cycling have increased rates of sleep problems

Women with a history of weight cycling - losing and regaining 10 pounds or more, even once - have increased rates of insomnia and other sleep problems, reports a study in The Journal of Cardiovascular Nursing, official journal of the Preventive Cardiovascular Nurses Association.

21 May 2021

Potential immunotherapy may improve cognitive and behavioral functions after stroke

Specialized immune cells that accumulate in the brain in the days and weeks after a stroke promote neural functions in mice, pointing to a potential immunotherapy that may boost recovery after the acute injury is over, University of Pittsburgh School of Medicine neurologists found.

19 May 2021

Study reveals four coagulation measures associated with migraine susceptibility

Nearly 15 percent of the U.S. population experiences migraine. One subtype of migraine that is not well understood is migraine with aura (MA).

19 May 2021

Diabetes-prevention program supports the addition of quality-adjusted life-years to average lifespan

You can do a lot in four years: go from white to black belt in taekwondo, plant a dwarf apple tree and pick its fruit, see your grandchild off to college and attend her graduation or get your own degree.

18 May 2021

Researchers report promising biotherapeutics for obesity and related medical complications

The research teams at the University of Hong Kong led by Professor Xuechen LI from the Research Division for Chemistry and Department of Chemistry, and Professor Yu WANG from the Department of Pharmacology and Pharmacy, reported a synthetic biotherapeutics with promising anti-tumor, insulin sensitising and hepatoprotective activities in the Journal of the American Chemical Society.

18 May 2021

COVID-19 pandemic causes disproportionate rise in cardiovascular deaths among racial, ethnic minorities

In the early months of the COVID-19 pandemic, the United States experienced higher rates of heart disease and cerebrovascular disease deaths, relative to the corresponding months the previous year.

18 May 2021

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo

18 May 2021

Researchers receive $4.5 million grant to improve quality of care for people with cardiovascular disease

Researchers from the University of Tennessee Health Science Center have received a $4.5 million grant over three years from the Agency for Healthcare Research and Quality (AHRQ) to lead a statewide network of primary care providers, health systems, and academic centers to identify, develop, and implement patient-centered approaches to improve quality of care and outcomes for people with cardiovascular disease.

18 May 2021

Study raises more concerns about the use of combined EPA/DHA through supplements

Doctors often recommend Omega-3s to help patients lower their cholesterol and improve heart health. Those Omega-3s can come from fatty fish like salmon and mackerel, or supplements that often contain a combination of the acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

17 May 2021

Delaying second dose of covid-19 vaccine could result in lower mortality under certain conditions

Delaying the second dose of covid-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain conditions, finds a US study published by The BMJ today.

17 May 2021

A leading group of scientists working in universities, research centres, and innovative companies across Belgium, Germany, Greece, Portugal, Spain, and Switzerland just initiated a groundbreaking project hoping to treat stroke once and for all. The project, given the code name “ANGIE”, is backed by EU funding. "European scientists started developin

17 May 2021

Scientists initiate a groundbreaking project to treat stroke once and for all

A leading group of scientists working in universities, research centers, and innovative companies across Belgium, Germany, Greece, Portugal, Spain, and Switzerland just initiated a groundbreaking project hoping to treat stroke once and for all.

17 May 2021

Stroke News and Research

Further Reading

Prism adaptation treatment enhances functional, cognitive outcomes in people with spatial neglect

Researchers identify mechanism that may lead to new therapies for strokes, brain injuries

Kennedy Krieger Institute researcher wins NIH award for movement learning study

Researchers identify interventions to improve rehabilitation outcomes for people with spatial neglect

New insights into white matter changes may offer novel targets for prevention, therapies

Little evidence for mRNA COVID-19 vaccine-associated thrombocytopenia, suggests new FDA study

Landmark study confirms that controlled blood pressure is key to prevent stroke, heart disease

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Women with history of weight cycling have increased rates of sleep problems

Potential immunotherapy may improve cognitive and behavioral functions after stroke

Study reveals four coagulation measures associated with migraine susceptibility

Diabetes-prevention program supports the addition of quality-adjusted life-years to average lifespan

Researchers report promising biotherapeutics for obesity and related medical complications

COVID-19 pandemic causes disproportionate rise in cardiovascular deaths among racial, ethnic minorities

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Researchers receive $4.5 million grant to improve quality of care for people with cardiovascular disease

Study raises more concerns about the use of combined EPA/DHA through supplements

Delaying second dose of covid-19 vaccine could result in lower mortality under certain conditions

Scientists initiate a groundbreaking project to treat stroke once and for all

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News